Genetic Studies into Inherited and Sporadic Hemolytic Uremic Syndrome
Overview
Affiliations
Hemolytic uremic syndrome (HUS) in adults carries a high morbidity and mortality, and its cause remains unknown despite many theories. Although familial HUS is rare, it affords a unique opportunity to elucidate underlying mechanisms that may have relevance to acquired HUS. We have undertaken a genetic linkage study based on a candidate gene approach. A common area bounded by the markers D1S212 and D1S306, a distance of 26 cM located at 1q32 segregated with the disease (Z max 3.94). We demonstrate that the gene for factor H lies within the region. Subsequent mutation analysis of the factor H gene has revealed two mutations in patients with HUS. In an individual with the sporadic/relapsing form of the disease we have found a mutation comprising a deletion, subsequent frame shift and premature stop codon leading to half normal levels of serum factor H. In one of the three families there is a point mutation in exon 20 causing an arginine to glycine change, which is likely to alter structure and hence function of the factor H protein. Factor H is a major plasma protein that plays a critical regulatory role in the alternative pathway of complement activation. In light of these findings and previous reports of HUS in patients with factor H deficiency, we postulate that abnormalities of factor H may be involved in the etiology of HUS.
Wu X, Liszewski M, Java A, Atkinson J Ann Blood. 2025; 8.
PMID: 39949759 PMC: 11824723. DOI: 10.21037/aob-22-40.
Tatematsu Y, Imaizumi T, Michihata N, Kato N, Kumazawa R, Matsui H Sci Rep. 2024; 14(1):18265.
PMID: 39107421 PMC: 11303750. DOI: 10.1038/s41598-024-68736-6.
Avdonin P, Blinova M, Generalova G, Emirova K, Avdonin P Biomolecules. 2024; 14(1).
PMID: 38254639 PMC: 10813406. DOI: 10.3390/biom14010039.
Genetic investigation of Nordic patients with complement-mediated kidney diseases.
Rydberg V, Aradottir S, Kristoffersson A, Svitacheva N, Karpman D Front Immunol. 2023; 14:1254759.
PMID: 37744338 PMC: 10513385. DOI: 10.3389/fimmu.2023.1254759.
Brocklebank V, Walsh P, Smith-Jackson K, Hallam T, Marchbank K, Wilson V Blood. 2023; 142(16):1371-1386.
PMID: 37369098 PMC: 10651868. DOI: 10.1182/blood.2022018833.